Agostoni E, Zocchi L. 1998. Mechanical coupling and liquid exchanges in the pleural space. Clin Chest Med 19:241–260.
Antonini JM, Charron TG, Roberts JR, Lai J, Blake TL, Rogers RA. 1999. Application of laser scanning confocal microscopy in the analysis of particle-induced pulmonary fibrosis. Toxicol Sci 51:126–134.
Bermudez E, Mangum JB, Moss OR, Wong BA, Everitt JI. 2003. Pleural dosimetry and pathobiological responses in rats and hamsters exposed subchronically to MMVF 10a fiberglass. Toxicol Sci 74:165–173.
Bernstein DM, Hoskins JA. 2006. The health effects of chrysotile: current perspective based upon recent data. Regul Toxicol Pharmacol 45:252–264.
Bernstein DM, Rogers R, Smith P. 2004. The biopersistence of brazilian chrysotile asbestos following inhalation. Inhal Toxicol 16:745–761.
Bernstein DM, Chevalier J, Smith P. 2005. Comparison of Calidria chrysotile asbestos to pure tremolite: final results of the inhalation biopersistence and histopathology examination following short- term exposure. Inhal Toxicol 17:427–449.
Bernstein DM, Donaldson K, Decker U, Gaering S, Kunzendorf P, Chevalier J, Holm SE. 2008. A biopersistence study following exposure to chrysotile asbestos alone or in combination with fine particles. Inhal Toxicol 20:1009–1028.
Bernstein D, Rogers R, Smith P. 2005. The biopersistence of Canadian chrysotile asbestos following inhalation: final results through 1 year after cessation of exposure. Inhal Toxicol 17:1–14.
Bernstein DM, Rogers RA, Sepulveda R, Donaldson K, Schuler D, Gaering S, Kunzendorf P, Chevalier J, Holm SE. 2010. The pathological response and fate in the lung and pleura of chrysotile 
Brorby GP, Sheehan PJ, Berman DW, Greene JF, Holm SE. 2008. Re-creation of historical chrysotile-containing joint compounds. Inhal Toxicol 20:1043–1053.
Cannon WC, Blanton EF, McDonald KE. 1983. The flow-past chamber: an improved nose-only exposure system for rodents. Am Ind Hyg Assoc J 44:923–928.
European Commission. 1999. ECB/TM/26 rev.7. Methods for the determination of the hazardous properties for human health of man made mineral fibers (MMMF). European Commission. Joint Research search Centre, Institute for Health and Consumer Protection, Unit: Toxicology and Chemical Substances, European Chemicals Bureau.
Fentie IH, Allen DJ, Schenck MH, Didio LJ. 1986. Comparative electron microscopic study of bovine, porcine and human parietal pericardium, as materials for cardiac valve bioprostheses. J Submicrosc Cytol 18:53–65.
Hesterberg TW, Chase G, Axten C, Miller WC, Musselman RP, Kamstrup O, Hadley J, Morscheidt C, Bernstein DM, Thevenaz P. 1998. Biopersistence of synthetic vitreous fibers and amosite asbestos in the rat lung following inhalation. Toxicol Appl Pharmacol 151:262–275.
Hesterberg TW, Axten C, McConnell EE, Hart GA, Miiller W, Chevalier J, Everitt J, Thevenaz P, Oberdörster G. 1999. Studies on the inhalation toxicology of two fiberglasses and amosite asbestos in the syrian golden hamster. Part I. Results of a subchronic study and dose selection for a chronic study. Inhal Toxicol 11:747–784.
Hesterberg TW, Axten C, McConnell EE, Oberdörster G, Everitt J, Miiller WC, Chevalier J, Chase GR, Thevenaz P. 1997. Chronic inhalation study of fiber glass and amosite asbestos in hamsters: twelve-month preliminary results. Environ Health Perspect 105 Suppl 5:1223–1229.
Huggins JT, Sahn SA. 2004. Causes and management of pleural fibrosis. Respirology 9:441–447.
Idell S, Mazar AP, Bitterman P, Mohla S, Harabin AL. 2001. Fibrin turnover in lung inflammation and neoplasia. Am J Respir Crit Care Med 163:578–584.
Jantz MA, Antony VB. 2008. Pathophysiology of the pleura. Respiration 75:121–133.
Luoto K, Holopainen M, Kangas J, Kalliokoski P, Savolainen K. 1995. The effect of fiber length on the dissolution by macrophages of rockwool and glasswool fibers. Environ Res 70:51–61.
McConnell EE, Axten C, Hesterberg TW, Chevalier J, Miiller WC, Everitt J, Oberdörster G, Chase GR, Thevenaz P, Kotin P. 1999. Studies on the inhalation toxicology of two fiberglasses and amosite asbestos in the Syrian golden hamster. Part II. Results of chronic exposure. Inhal Toxicol 11:785–835.
Morimoto Y, Yamato H, Kido M, Tanaka I, Higashi T, Fujino A, Yokosaki Y. 1994. Effects of inhaled ceramic fibres on macrophage function of rat lungs. Occup Environ Med 51:62–67.
Muhle H, Pott F, Bellmann B, Takenaka S, Ziem U. 1987. Inhalation and injection experiments in rats to test the carcinogenicity of MMMF. Ann Occup Hyg 31:755–764.
Noppen M, De Waele M, Li R, Gucht KV, D’Haese J, Gerlo E, Vincken W. 2000. Volume and cellular content of normal pleural fluid in humans examined by pleural lavage. Am J Respir Crit Care Med 162:1023–1026.
Peng MJ, Wang NS, Vargas FS, Light RW. 1994. Subclinical surface alterations of human pleura. A scanning electron microscopic study. Chest 106:351–353.
Pundsack FL. 1955. The properties of asbestos. I. The colloidal and surface chemistry of chrysotile. J Phys Chem 59:892–895.
Rogers RA, Antonini JM, Brismar H, Lai J, Hesterberg TW, Oldmixon EH, Thevenaz P, Brain JD. 1999. In situ microscopic analysis of asbestos and synthetic vitreous fibers retained in hamster lungs following inhalation. Environ Health Perspect 107:367–375.
Schneider F, Sporn TA, Roggli VL. 2010. Asbestos fiber content of lungs with diffuse interstitial fibrosis: An analytical scanning electron microscopic analysis of 249 cases. Arch Pathol Lab Med 134:457– 461.2nd edn. Hodder Education: Hachette UK Company, London.